Last reviewed: May 12, 2026
Last updated: May 12, 2026
Written by:
Jay Hastings
,
CEO of PlexusDx
Start your GLP-1 program with PlexusDx
One all-inclusive price covers your online provider visit, prescription, compounded medication, and shipping — no membership, no hidden fees. Complete a short intake and a licensed provider takes it from there.
Start your intake →
Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance. His work has included scaling healthcare startups, leading CLIA lab integrations, and helping expand consumer access to precision health tools.
Medically reviewed by:
Jayden Lee, PharmD, EMBA
Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.
The Impact of the FTO Gene on Obesity and Health
The FTO gene demonstrates its impact on obesity through its essential role in modifying eating behaviors and body weight which creates significant health risks for individuals. FTO represents the fat mass and obesity-associated gene which holds the distinction of being the most researched gene related to body weight and obesity. The FTO gene holds the distinction of being the initial genetic discovery connected to obesity and continues to have the greatest documented influence on body weight currently known. Research indicates that FTO functions as a "master switch" to control multiple weight-related genes and pathways in our bodies although its precise role remains unclear. FTO affects body weight through its effects on appetite control and emotional eating behaviors as well as food choice preferences. FTO could negatively affect both fat metabolism and energy expenditure. The SNP rs9939609 in the FTO gene shows a strong correlation with obesity which affects individuals of multiple age groups and ethnic backgrounds. People who possess the minor 'A' allele experience higher weight gain and show greater obesity prevalence. Research indicates that people possessing the 'A' allele show multiple traits including elevated ghrelin levels and increased food consumption along with preferences for calorie-rich foods and less meal satisfaction which leads to eating without hunger and food cravings that result in emotional and binge eating. Individuals with the 'T' allele typically maintain normal body weight while experiencing greater meal satiety and making healthier food selections. The FTO SNP rs9939609 affects appetite and hunger regulation while also impacting the body's metabolic processing of food. Research shows that people with the 'A' allele experience both greater insulin resistance and elevated blood sugar levels. Research findings show that people who have type-2 diabetes frequently possess the 'A' allele which could raise their diabetes development risk as time passes. The effect of this allele on diabetes risk shows different patterns across various populations. A healthy diet provides individuals with the 'A' variant protection against its negative health effects. Research confirms that this variant's carriers benefit from weight reduction and decreased abdominal fat when they follow a low-fat diet or substitute saturated fats with polyunsaturated and monounsaturated fats alongside lower total cholesterol and LDL cholesterol levels plus reduced inflammation markers and insulin resistance. Dietary protein intake increases can help 'A' variant carriers by enhancing appetite regulation and food craving control while also reducing their total cholesterol, triglycerides, LDL cholesterol, and insulin resistance levels. Some meta-analyses do not support associations between FTO variants and BMI while others indicate that high protein consumption strengthens the FTO variant-BMI relationship for specific groups. A three-year investigation demonstrated that individuals with the 'AA' genotype experience better weight loss outcomes on a Mediterranean diet than those with the 'TT' genotype. People who carry the 'AA' genotype might protect themselves from developing diabetes by following this particular diet. By learning about the impact of FTO gene variants on weight and health people can make educated dietary decisions that help reduce their genetic risk for obesity and related health issues. A personalized nutritional plan based on one's genetic makeup enables people to achieve better weight control alongside improved general health. Uncover your personalized health and wellness potential through Precision Health & Wellness tests from PlexusDx which you can find on PlexusDx.com as well as Amazon and Walmart.
Frequently Asked Questions
What does FTO stand for and why is it so heavily studied?
FTO stands for fat mass and obesity-associated gene. This article calls it the most researched gene related to body weight, the first genetic discovery connected to obesity, and the one with the largest documented influence on body weight known so far. It adds that research describes FTO as a master switch controlling multiple weight-related genes and pathways, while conceding its precise role remains unclear.
What does this article say about the A allele of rs9939609?
It says carriers of the minor A allele show greater weight gain and higher obesity prevalence, and links the allele to elevated ghrelin, increased food intake, preference for calorie-rich foods, less meal satisfaction, eating without hunger, cravings, and emotional or binge eating. It also reports greater insulin resistance and higher blood sugar in A allele carriers. These are group-level associations, not descriptions of any one person.
Does carrying the FTO A allele mean weight loss efforts will not work?
No. This article argues the opposite, saying a healthy diet offers A allele carriers protection against the variant's negative effects. It reports carriers benefiting from lower-fat eating or replacing saturated fats with polyunsaturated and monounsaturated fats, and from higher protein intake helping appetite regulation. It also cites a three-year study where AA carriers lost more weight on a Mediterranean diet, though it names no source.
Is the FTO and BMI link settled science according to this article?
Not entirely. The article says some meta-analyses do not support an association between FTO variants and BMI, while others suggest high protein consumption strengthens the variant-BMI relationship in specific groups. It also says the allele's effect on diabetes risk follows different patterns across populations. Even the most studied obesity gene produces inconsistent findings, which is worth remembering before treating any result as decisive.
How does this article describe the T allele of rs9939609?
It says T allele carriers typically maintain normal body weight, feel greater satiety after meals and make healthier food choices, framing this as the counterpart to the A allele. That is stated far too absolutely. No single variant keeps anyone at a normal weight, and body weight reflects diet, activity, sleep, medications, health conditions and environment. Read it as an average tendency in study populations at most.
Medical and Editorial Standards
Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.
Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance. References are included at the end of the article when scientific, medical, or health-related claims are discussed.
Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.
Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.
Share:
Why Do Alkaline Phosphatase Levels Reveal Health and Genetics?
How does Free T3 affect thyroid health and well-being optimization?